Y-mAbs Therapeutics Inc.

06/09/2024 | Press release | Distributed by Public on 06/09/2024 18:48

Y-mAbs Presents Neuroblastoma Research on Naxitamab and SADA PRIT Technology Platform at AACR Special Conference on Advances in Pediatric Cancer Research